Using a new diagnostic tool to predict lymph node metastasis in advanced epithelial ovarian cancer leads to simple lymphadenectomy decision rules: A multicentre study from the FRANCOGYN group.

Date publication

janvier 2021

Journal

PloS one

Auteurs

Membres identifiés du Cancéropôle Est :
Pr COUTANT Charles

Tous les auteurs :
Mimoun C, Paoletti X, Gaillard T, Crestani A, Benifla JL, Mezzadri M, Bendifallah S, Touboul C, Bricou A, Dabi Y, Canlorbe G, Kerbage Y, Lavoué V, Ouldamer L, Lecointre L, Coutant C, Fauconnier A, Rouzier R, Huchon C

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/34665839

Résumé

The aim of this study was to develop a new diagnostic tool to predict lymph node metastasis (LNM) in patients with advanced epithelial ovarian cancer undergoing primary cytoreductive surgery.

Référence

PLoS One. 2021 ;16(10):e0258783